MDLN
Income statement / Annual
Last year (2024), Medline Inc.'s total revenue was $25.51 B,
an increase of 9.80% from the previous year.
In 2024, Medline Inc.'s net income was $1.20 B.
See Medline Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$25.51 B |
$23.23 B |
$21.45 B |
| Cost of Revenue |
$19.22 B
|
$18.01 B
|
$16.89 B
|
| Gross Profit |
$6.29 B
|
$5.22 B
|
$4.56 B
|
| Gross Profit Ratio |
0.25
|
0.22
|
0.21
|
| Research and Development Expenses |
$67.00 M
|
$60.00 M
|
$58.00 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.04 B
|
$3.81 B
|
$3.62 B
|
| Other Expenses |
-$42.00 M
|
-$88.00 M
|
$11.00 M
|
| Operating Expenses |
$4.07 B
|
$3.78 B
|
$3.69 B
|
| Cost And Expenses |
$23.28 B
|
$21.79 B
|
$20.58 B
|
| Interest Income |
$280.00 M
|
$237.00 M
|
$27.00 M
|
| Interest Expense |
$1.31 B
|
$1.38 B
|
$911.00 M
|
| Depreciation & Amortization |
$977.00 M
|
$951.00 M
|
$933.00 M
|
| EBITDA |
$3.53 B |
$2.59 B |
$1.85 B |
| EBITDA Ratio |
0.14
|
0.11
|
0.09
|
| Operating Income Ratio |
0.09
|
0.06
|
0.04
|
| Total Other Income/Expenses Net |
-$979.00 M
|
-$1.18 B
|
-$860.00 M
|
| Income Before Tax |
$1.25 B
|
$264.00 M
|
$10.00 M
|
| Income Before Tax Ratio |
0.05
|
0.01
|
0
|
| Income Tax Expense |
$46.00 M
|
$30.00 M
|
$35.00 M
|
| Net Income |
$1.20 B
|
$234.00 M
|
-$25.00 M
|
| Net Income Ratio |
0.05
|
0.01
|
-0
|
| EPS |
1.52 |
0.3 |
-0.0318 |
| EPS Diluted |
1.52 |
0.3 |
-0.0318 |
| Weighted Average Shares Out |
$787.12 M
|
$787.12 M
|
$787.12 M
|
| Weighted Average Shares Out Diluted |
$787.12 M
|
$787.12 M
|
$787.12 M
|
| Link |
|
|
|
